2020
DOI: 10.7759/cureus.12088
|View full text |Cite
|
Sign up to set email alerts
|

Spectrum and Clinical Outcome of Motility Disorders on High-Resolution Esophageal Manometry: A Study From a Tertiary Center on Patients With Dysphagia in Pakistan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 21 publications
1
2
0
Order By: Relevance
“…[24] In our study, barium esophagogram was suggestive for the diagnosis of achalasia in 80.64% of patients. This was in accordance with Rehman et al [17] who recorded in their cross-sectional study that barium esophagogram was sensitive for the diagnosis of achalasia proved by HRM in 63.9% of the patients. Also, Schima et al [25] found that the diagnosis of achalasia by barium esophagogram was made in 58% of the patients with manometrically proven achalasia.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…[24] In our study, barium esophagogram was suggestive for the diagnosis of achalasia in 80.64% of patients. This was in accordance with Rehman et al [17] who recorded in their cross-sectional study that barium esophagogram was sensitive for the diagnosis of achalasia proved by HRM in 63.9% of the patients. Also, Schima et al [25] found that the diagnosis of achalasia by barium esophagogram was made in 58% of the patients with manometrically proven achalasia.…”
Section: Discussionsupporting
confidence: 92%
“…Twenty percent patients had normal manometry. Also, Rehman et al [ 17 ] who have demonstrated that achalasia was the most common diagnosis in their studied cases (35.6%) followed by DES (13.0%). Then weak peristalsis with large peristaltic defects was less common (7.9%).…”
Section: Discussionmentioning
confidence: 77%
“…Serotonin and norepinephrine reuptake inhibitors are antidepressants and act by binding to the serotonin and norepinephrine transporters (73). Serotonin and norepinephrine reuptake inhibitors also act in the lower esophageal function (Level 2b; Grade: B) (74,75). However, no study addresses their use in achalasia patients, and consequently, their use should be restricted to research protocols (Level 5; Grade: D).…”
Section: Serotonin and Norepinephrine Reuptake Inhibitorsmentioning
confidence: 99%